Target Price | $272.29 |
Price | $242.85 |
Potential | 12.12% |
Number of Estimates | 21 |
21 Analysts have issued a price target JPMorgan Chase & Co. 2026 . The average JPMorgan Chase & Co. target price is $272.29. This is 12.12% higher than the current stock price. The highest price target is $330.00 35.89% , the lowest is $220.00 9.41% . | |
A rating was issued by 27 analysts: 16 Analysts recommend JPMorgan Chase & Co. to buy, 9 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the JPMorgan Chase & Co. stock has an average upside potential 2026 of 12.12% . Most analysts recommend the JPMorgan Chase & Co. stock at Purchase. |
15 Analysts have issued a sales forecast JPMorgan Chase & Co. 2025 . The average JPMorgan Chase & Co. sales estimate is $177b . This is 37.33% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $191b 32.35% , the lowest is $171b 39.41% .
This results in the following potential growth metrics:
2024 | $282b | 16.71% |
---|---|---|
2025 | $177b | 37.13% |
2026 | $184b | 4.06% |
2027 | $190b | 3.22% |
22 JPMorgan Chase & Co. Analysts have issued a net profit forecast 2025. The average JPMorgan Chase & Co. net profit estimate is $52.1b . This is 5.63% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $66.6b 20.51% , the lowest is $46.6b 15.70% .
This results in the following potential growth metrics and future Net Margins:
2024 | $55.3b | 21.69% |
---|---|---|
2025 | $52.1b | 5.63% |
2026 | $56.2b | 7.78% |
2027 | $61.0b | 8.61% |
2024 | 19.61% | 4.27% |
---|---|---|
2025 | 29.43% | 50.11% |
2026 | 30.48% | 3.57% |
2027 | 32.07% | 5.22% |
22 Analysts have issued a JPMorgan Chase & Co. forecast for earnings per share. The average JPMorgan Chase & Co. EPS is $18.64 . This is 5.62% lower than earnings per share in the financial year 2024. The highest EPS forecast is $23.80 20.51% , the lowest is $16.65 15.70% .
This results in the following potential growth metrics and future valuations:
2024 | $19.75 | 21.69% |
---|---|---|
2025 | $18.64 | 5.62% |
2026 | $20.09 | 7.78% |
2027 | $21.82 | 8.61% |
Current | 12.30 | 1.49% |
---|---|---|
2025 | 13.03 | 5.93% |
2026 | 12.09 | 7.21% |
2027 | 11.13 | 7.94% |
Based on analysts' sales estimates for 2025, the JPMorgan Chase & Co. stock is valued at an EV/Sales of 8.11 and an P/S ratio of 3.83 .
This results in the following potential growth metrics and future valuations:
Current | 5.08 | 0.00% |
---|---|---|
2025 | 8.11 | 59.66% |
2026 | 7.79 | 3.90% |
2027 | 7.55 | 3.12% |
Current | 2.40 | 2.87% |
---|---|---|
2025 | 3.83 | 59.56% |
2026 | 3.68 | 3.90% |
2027 | 3.57 | 3.12% |
JPMorgan Chase & Co....
Analyst | Rating | Action | Date |
---|---|---|---|
Truist Securities |
Hold
➜
Hold
|
Unchanged | Jan 16 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jan 16 2025 |
Keefe, Bruyette & Woods |
Market Perform
➜
Market Perform
|
Unchanged | Jan 16 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Jan 16 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Jan 07 2025 |
Truist Securities |
➜
Hold
|
Initiated | Jan 07 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jan 06 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Jan 16 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jan 16 2025 |
Unchanged
Keefe, Bruyette & Woods:
Market Perform
➜
Market Perform
|
Jan 16 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Jan 16 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jan 07 2025 |
Initiated
Truist Securities:
➜
Hold
|
Jan 07 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jan 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.